The biological activity of covalently immobilized heparin.
D000614:Aminocaproates; D001672:Biocompatible Materials / Q000138:chemical synthesis*; D002234:Carbodiimides; D055598:Chemical Phenomena; D002621:Chemistry; D003488:Cyanogen Bromide; D006493:Heparin / Q000494:pharmacology*; D007700:Kinetics; D009025:Morpholines; D010705:Phosgene; D011108:Polymers / Q000494:pharmacology*; D011134:Polysaccharides; D011700:Putrescine; D013329:Structure-Activity Relationship; D013451:Sulfonic Acids; D013462:Sulfur Radioisotopes; D013499:Surface Properties; D013917:Thrombin / Q000032:analysis; D013927:Thrombosis / Q000517:prevention & control
D000614:Aminocaproates; D001672:Biocompatible Materials; D002234:Carbodiimides; D009025:Morpholines; D011108:Polymers; D011134:Polysaccharides; D013451:Sulfonic Acids; D013462:Sulfur Radioisotopes; D010705:Phosgene; D006493:Heparin; D013917:Thrombin; D003488:Cyanogen Bromide; D011700:Putrescine